Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-structural protein 4A (NS4A) is a small, 54-amino acid transmembrane protein encoded by the Hepatitis C virus (HCV) that acts as an essential cofactor for the NS3 serine protease [2, 3]. The formation of the NS3/4A complex is critical for viral maturation, as it catalyzes the proteolytic cleavage of the HCV polyprotein at four specific sites to generate mature NS3, NS4A, NS4B, NS5A, and NS5B proteins [4, 12]. Beyond its structural and catalytic role, NS4A anchors the protease complex to the endoplasmic reticulum membrane and facilitates the cleavage of host cell adaptor proteins such as MAVS (IPS-1) and TRIF, effectively dismantling the host's innate antiviral interferon response [5, 6]. Because of its absolute requirement for viral replication and immune evasion, the NS3/4A complex is a primary target for direct-acting antivirals (DAAs) [7, 10]. Modern NS3/4A protease inhibitors, such as glecaprevir and voxilaprevir, occupy the substrate-binding groove formed by the complex, leading to high cure rates in chronic hepatitis C patients, though the development of resistance-associated substitutions remains a clinical challenge [4, 8].
Binding and inhibition of the NS3/4A serine protease complex, preventing the cleavage of the viral polyprotein into functional units and blocking the degradation of host innate immune signaling proteins.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-structural protein 4A (Hepatitis C virus) (NS4A).